Hemanext Inc. has secured new venture-capital funding ahead of plans to seek U.S. regulatory authorization for a medical device designed to improve blood storage and help patients who depend heavily on donated blood.
Lexington, Mass.-based Hemanext has collected $15 million in new funding and has now raised a total of more than $100 million.
Donated…